These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25133669)

  • 1. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.
    Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; Lumbreras B; Hernández I; Gutiérrez F
    PLoS One; 2014; 9(8):e105442. PubMed ID: 25133669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients.
    Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; López N; Gutiérrez F
    PLoS One; 2013; 8(5):e64327. PubMed ID: 23717597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Human Herpesvirus 8 and Herpes Simplex Type 2 to Progression of Carotid Intima-Media Thickness in People Living With HIV.
    Lidón F; Padilla S; García JA; Fernández M; García J; Ortiz de la Tabla V; Gutiérrez F; Masiá M
    Open Forum Infect Dis; 2019 Feb; 6(2):ofz041. PubMed ID: 30815506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
    Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
    PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum apoptosis markers in HIV-infected patients with human herpesvirus type 8 and herpes simplex virus type 2 co-infection.
    Dakovic Rode O; Markotic A; Kujundzic Tiljak M; Zidovec Lepej S; Begovac J
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3303-8. PubMed ID: 22837067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
    Foster WR; Bischin A; Dorer R; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.
    Yap SH; Abdullah NK; McStea M; Takayama K; Chong ML; Crisci E; Larsson M; Azwa I; Kamarulzaman A; Leong KH; Woo YL; Rajasuriar R
    PLoS One; 2017; 12(10):e0186000. PubMed ID: 29016635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
    Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
    AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
    Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
    Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
    Kovacs A; Karim R; Mack WJ; Xu J; Chen Z; Operskalski E; Frederick T; Landay A; Voris J; Spencer LS; Young MA; Tien PC; Augenbraun M; Strickler HD; Al-Harthi L
    J Infect Dis; 2010 Mar; 201(6):823-34. PubMed ID: 20151840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
    Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
    HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
    Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
    Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
    J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection.
    Silva DMD; Gonçales JP; Silva Júnior JVJ; Lopes TRR; Bezerra LA; Barros de Lorena VM; Duarte Coêlho MRC
    J Med Virol; 2021 Jun; 93(6):4033-4037. PubMed ID: 32926412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
    Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
    Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
    Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
    J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.